Danone (BN) leads bid for Made Group, eyeing $1.5bn strategic expansion
Danone is reportedly the leading bidder for Made Group, an Australian company known for its premium dairy and plant-based brands, Cocobella and Rokeby Farms. The potential acquisition, valued at over $1.5 billion, would mark a strategic expansion for the French food giant. Danone shares are up 0.5% today, trading at €66.42 on 30 April 2026, following yesterday's close at €66.10.
Strategic Reinforcement in Wellness
Should the transaction proceed, it would strengthen Danone's position within the health and wellness segment, a key strategic focus for the group. Integrating Made Group's recognised premium dairy and plant-based beverages would broaden Danone's portfolio and expand its presence in growth markets. This move aligns with Danone's ongoing efforts to adapt to evolving consumer preferences for healthier and plant-based options.
The news of the potential acquisition, first reported on 27 April 2026, follows Danone's recent positive quarterly results. The company reported strong first-quarter 2026 revenue driven by comparable growth, as detailed in an analysis published on 28 April 2026. Shares had experienced a slight decline yesterday, 29 April 2026, after a movement observed following the announcement of the ex-dividend date. The proposed Made Group acquisition could therefore provide a new growth catalyst for the group.
Why Danone's Bid for Made Group Is Stirring Excitement
Danone operates as a global food company, primarily known for its dairy, plant-based products, and bottled water. It generates revenue by selling a wide array of everyday consumer goods, from yoghurts and plant-based drinks to mineral water, serving millions of consumers worldwide. The company has carved out a strong position in the health and wellness sector, a market that continues to evolve rapidly.
The primary driver behind Danone's share price movement today is the news that the French giant is reportedly the leading bidder for Made Group, an Australian company with a portfolio of premium dairy and plant-based brands. This potential acquisition, valued at over $1.5 billion, is seen as a significant strategic move. It aims to bolster Danone's presence in high-growth markets and expand its offerings in popular categories, particularly plant-based beverages, following a period of positive quarterly results.
This prospect of strategic expansion has been well-received by the market. Danone's stock, trading under the symbol BN, is currently up 0.5% on 30 April 2026, exchanging hands at €66.42, having closed yesterday at €66.10.
Think of a seasoned chef who decides to acquire a highly regarded, specialty ingredient producer. This isn't just about adding more items to the menu; it's about integrating unique, on-trend flavours that perfectly complement the chef's existing culinary style and attract a new, discerning clientele, promising an even more exciting dining experience.
Danone
Danone S.A. (BN) is a global food and beverage enterprise operating across Europe, North America, Latin America, Asia Pacific, Africa, and the Middle East. Its operations are structured into three key segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. The company manufactures and distributes a wide array of products, including yoghurts, milk products, plant-based alternatives, and ice creams under brands such as Actimel, Alpro, and evian, alongside licensed names like International Delight. Danone also provides specialized nutritional offerings for mothers, infants, and young children through brands like Aptamil and Nutrilon, as well as medical nutrition products under names such as Nutrison and Fortimel. Its water portfolio includes natural mineral waters and flavoured varieties from brands like Volvic and Bonafont. Products reach consumers via retail chains, convenience stores, healthcare facilities, and e-commerce channels. Danone S.A. was established in 1899 and is headquartered in Paris, France.